This lack of data, coupled with concern that VET may underestimate hypercoagulability in patients with cirrhosis due to its insensitivity to detect raised levels of VWF and the anti-coagulant action of the protein C system, were the main factors cited by EASL supporting their negative recommendation of VET to identify patients with cirrhosis at risk of venous thromboembolism [26]. Here, VWF is linked to Cirrhosis.